Khristopher J. Brooks is a reporter for CBS MoneyWatch. He previously worked as a reporter for the Omaha World-Herald, Newsday and the Florida Times-Union. His reporting primarily focuses on the U.S.

FILE - Jeffrey Reed, who experienced persistent sinus infections and two bouts of pneumonia while using a Philips CPAP machine, poses with the device at his home, Oct. 20, 2022, in Marysville, Ohio.

The FDA has received more than 500 reports of death tied to Philips’ recalled sleep apnea devices since 2021, according to a Jan. 31 agency update. The devicemaker recalled millions of ventilators and ...

The Food and Drug Administration says 561 deaths have been reported in connection to recalled Philips devices to treat obstructive sleep apnea and other breathing disorders. The FDA said that since ...

The U.S. Food and Drug Administration (FDA) has issued an update to a recall affecting millions of Philips sleep apnea machines, saying that they may be linked to at least 561 reported deaths. In a ...

Add Yahoo as a preferred source to see more of our stories on Google. Philips said Monday it will stop selling its sleep apnea machines in the US, more than two years after the Dutch manufacturer ...

This article originally appeared on ProPublica. ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story newsletter to receive stories like this one in your inbox.

FROM SHADYSIDE TONIGHT. PHILIPS REIS RUN ROAD RECALLED MILLIONS OF CPAPS BIPAPS AND VENTILATORS AFTER THE FDA SAID FOAM INSULATION INSIDE THOSE MACHINES WAS A HEALTH RISK. BUT IN A LAWSUIT, PHILIPS ...

The company responsible for a global recall of sleep apnea machines will be barred from resuming production at U.S. facilities until it meets a number of safety requirements, under a long-awaited ...

WASHINGTON — A device made by Philips Respironics for treating sleep apnea should be monitored closely when in use because it can overheat, according to federal regulators. The Food and Drug ...

The move comes as Philips has agreed to a consent decree with the Food and Drug Administration and the Department of Justice that could cost the company nearly $400 million. In June 2021, Philips ...